In this respect, it is interesting to note that we found significantly higher levels of IgG in the plasma and myocardium of patients with ARVC, as well as co-localisation between IgG and complement proteins. This evidence concerns the gene VTN and arrhythmogenic right ventricular cardiomyopathy.